Longevity
Altimmune gets analyst boost as MASH data grow
A fresh analyst upgrade and encouraging clinical data are strengthening the case for pemvidutide and the future of liver health. The first wave of GLP-1 drugs changed the conversation around obesity. They helped people eat less and lose weight, but they also raised a bigger question: what comes next? For many researchers, the future isn’t […] The post Altimmune gets analyst boost as MASH data grow appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →